Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 162

Sort by

Sort Order Select

Journal Articles

Significance of the Apoptotic Regulators BAX, BCL2, BCL- XL and MCL1 in Newly Diagnosed AML

Sarah J Philip, Valeria Visconte, Hetty E. Carraway, Aaron T. Gerds, Abhay Singh, Sophia Balderman, John C Molina, Moaath K. Mustafa-Ali, Sudipto Mukherjee, Jaroslaw P. Maciejewski, Anjali S. Advani

Blood (2023) 142 (Supplement 1): 5995.

https://doi.org/10.1182/blood-2023-185081

Published: 2023

Journal Articles

Symptom Burden in Idiopathic Multicentric Castleman Disease: Protocol for the Development of a Novel Standardized Patient Reported Outcome Measure

Sudipto Mukherjee, Philip A Powell, Jill Carlton, Clara Murukia, Antonio Adolfo Guerra Soares Brandão, Karthik Ramasamy, Frankie Shupo, Grace Wayi-Wayi, Karan Kanhai, Kelley C Dacus, Kelly Makarounas-Kirchmann, Anju Devianee Keetharuth

Blood (2023) 142 (Supplement 1): 7342.

https://doi.org/10.1182/blood-2023-186256

Published: 2023

Journal Articles

Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL)

Blood (2023) 142 (Supplement 1): 1798.

https://doi.org/10.1182/blood-2023-187744

Published: 2023

Journal Articles

Decreased Survival Among Patients with Indolent Systemic Mastocytosis: A Population-Level Retrospective Cohort Analysis Using Healthcare Claims Dataset

Sudipto Mukherjee, Douglas J Cattie, Daniel Shaheen, Dakota Powell, Teresa Green

Blood (2023) 142 (Supplement 1): 75.

https://doi.org/10.1182/blood-2023-188617

Published: 2023

Journal Articles

Risk of Myelodysplastic Syndromes (MDS) in Adolescents and Young Adults with Cancers Treated with Chemotherapy with or without Radiotherapy

Rahul Mishra, Xuefei Jia, Debolina Pramanik, Abhay Singh, Sindhusha Veeraballi, Sophia Balderman, John C Molina, Anjali S. Advani, Moaath K. Mustafa-Ali, Hetty E. Carraway, Aaron T. Gerds, Nargiz F Muganlinskaya, Sudipto Mukherjee

Blood (2023) 142 (Supplement 1): 2351.

https://doi.org/10.1182/blood-2023-190692

Published: 2023

Journal Articles

Risk of Therapy-Related Acute Myeloid Leukemia (t-AML) in Adolescent and Young Adults Cancer Patients Treated with Chemotherapy with or without Radiotherapy: A National Population-Based Cohort Study Using SEER Registry

Rahul Mishra, Abhay Singh, Sindhusha Veeraballi, Sophia Balderman, John C Molina, Anjali S. Advani, Moaath K. Mustafa-Ali, Hetty E. Carraway, Aaron T. Gerds, Nargiz F Muganlinskaya, Sudipto Mukherjee

Blood (2023) 142 (Supplement 1): 377.

https://doi.org/10.1182/blood-2023-190353

Published: 2023

Journal Articles

A Model of Cumulative Risk of Disease Progression Among Patients with Indolent Systemic Mastocytosis

Sudipto Mukherjee, Douglas J Cattie, Daniel Shaheen, Teresa Green, Dakota Powell

Blood (2023) 142 (Supplement 1): 6406.

https://doi.org/10.1182/blood-2023-188806

Published: 2023

Journal Articles

The Epidemiology of Cardiovascular Disease in African American Patients with Myeloid Neoplasms: A SEER Data Analysis

Sindhusha Veeraballi, Yanwen Chen, Hetty E. Carraway, Aaron T. Gerds, Moaath K. Mustafa Ali, Arooj Ahmed, Anjali S. Advani, John C Molina, Sophia Balderman, Jaroslaw P. Maciejewski, Sudipto Mukherjee, Abhay Singh

Blood (2023) 142 (Supplement 1): 5181.

https://doi.org/10.1182/blood-2023-189294

Published: 2023

Journal Articles

Race and Gender Representation in Myelodysplastic Syndrome Clinical Trials in the US: A Cohort Study

Sindhusha Veeraballi, Ran Zhao, Megha Sai Konka, Hetty E. Carraway, Moaath K. Mustafa Ali, Aaron T. Gerds, Arooj Ahmed, Anjali S. Advani, John C Molina, Sophia Balderman, Abhay Singh, Sudipto Mukherjee

Blood (2023) 142 (Supplement 1): 1855.

https://doi.org/10.1182/blood-2023-189959

Published: 2023

Journal Articles

Risk of Therapy-Related Acute Myeloid Leukemia (t-AML) in Cancer Patients Treated with Chemotherapy with or without Radiotherapy: A National Population-Based Cohort Study Using SEER Registry

Julia H. Joo, Yanwen Chen, Aaron T. Gerds, Anjali Advani, Sophia R. Balderman, Hetty E. Carraway, Abhay Singh Singh, Sudipto Mukherjee

Blood (2022) 140 (Supplement 1): 687–689.

https://doi.org/10.1182/blood-2022-163565

Published: 2022

Journal Articles

A Clinically Practicable Approach to Predict TP53 Allelic Configurations in Myeloid Neoplasia

Blood (2022) 140 (Supplement 1): 2075–2077.

https://doi.org/10.1182/blood-2022-162913

Published: 2022

Journal Articles

Exploratory Validation of a Bespoke International Patient Symptom Survey in Idiopathic Multicentric Castleman's Disease Using Psychometric Testing: Implications for Clinical Practice and Routine Data Collection

Sudipto Mukherjee, Matthew Franklin, Francis Shupo, Nicola Mason, Grace Wayi-Wayi, Natasa Zibelnik, Mileva Repasky, John Brazier

Blood (2022) 140 (Supplement 1): 10885–10886.

https://doi.org/10.1182/blood-2022-168744

Published: 2022

Journal Articles

Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Elias Jabbour, Paul B. Koller, Vivian G. Oehler, Omer H Jamy, Sudipto Mukherjee, Anthony M. Hunter, Maria R. Baer, Joseph T. Beck, Zi Chen, Huanshan Guo, Lei Fu, Lichuang Men, Hengbang Wang, Dajun Yang, Yifan Zhai, Hagop Kantarjian, Lixin Jiang, Cunlin Wang

Blood (2022) 140 (Supplement 1): 200–202.

https://doi.org/10.1182/blood-2022-162387

Published: 2022

Journal Articles

Clinical and Molecular Features of FTL3 non Canonical and Activation Loop Mutations

Jaymeson Gordon, Christopher Haddad, Ishani Nautiyal, Yasuo Kubota, Hetty E. Carraway, Sudipto Mukherjee, Aaron T. Gerds, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Carmelo Gurnari, Valeria Visconte

Blood (2022) 140 (Supplement 1): 9152–9154.

https://doi.org/10.1182/blood-2022-170094

Published: 2022

Journal Articles

Patterns of Disease Progression in Patients with Systemic Mastocytosis: A US Population-Level Analysis Using Health Claims-Based Dataset

Sudipto Mukherjee, Doug Cattie, Naveen Pemmaraju, Teresa Green, Dan Shaheen

Blood (2022) 140 (Supplement 1): 6865–6867.

https://doi.org/10.1182/blood-2022-169269

Published: 2022

Journal Articles

Real-World Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Luspatercept: An Evaluation of US Clinical Practice Utilization and Treatment Patterns

Sudipto Mukherjee, Cherrishe Brown-Bickerstaff, Ali McBride, Ajeet Gajra, Danielle Gentile, Angelica Falkenstein, Talia Miller, JaLyna Laney, Kristin M. Savill, Adeola Y. Makinde

Blood (2022) 140 (Supplement 1): 944–946.

https://doi.org/10.1182/blood-2022-156902

Published: 2022

Journal Articles

Real-World Usage of Asciminib in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) in the United States (US) Using a Large Claims Database

Sudipto Mukherjee, Chi-Chang Chen, Magdaliz Gorritz, Islam Sadek, Serban Iorga, Zifan Zhou, Jing He, Rodrigo Maegawa, Andrea Damon, Germano Ferreira, Kejal Jadhav

Blood (2022) 140 (Supplement 1): 13297–13298.

https://doi.org/10.1182/blood-2022-166473

Published: 2022

Journal Articles

ANKRD26 Coding Variants in Myeloid Neoplasia

Teodora Kuzmanovic, Metis Hasipek, Samuel Li, Thomas Laframboise, Valeria Visconte, Sunisa Kongkiatkamon, Seth J. Corey, Sudipto Mukherjee, Anjali Advani, Aaron T. Gerds, Yogenthiran Saunthararajah, Sophia R. Balderman, Abhay Singh Singh, Hetty E. Carraway, Niroshan Nadarajah, Manja Meggendorfer, Jaroslaw P. Maciejewski, Bhumika J. Patel

Blood (2022) 140 (Supplement 1): 4013–4015.

https://doi.org/10.1182/blood-2022-170645

Published: 2022

Journal Articles

Association of Clinical Characteristics at Diagnosis with Outcomes in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from a Real-World Medical Chart Review in the US

Sudipto Mukherjee, Kristin M. Savill, Ajeet Gajra, Danielle Gentile, Angelica Falkenstein, Talia Miller, JaLyna Laney, Ali McBride

Blood (2022) 140 (Supplement 1): 10998–11000.

https://doi.org/10.1182/blood-2022-156892

Published: 2022

Journal Articles

SEL24/MEN1703 Inhibits PIM/FLT3 Downstream Target in Acute Myeloid Leukemia (AML) Patients: Results of the Pharmacodynamics (PD) Assay and Genomic Profiling in the First-in-Human Diamond-01 Trial

Blood (2021) 138 (Supplement 1): 3436.

https://doi.org/10.1182/blood-2021-150277

Published: 2021

NARROW

Significance of the Apoptotic Regulators BAX, BCL2, BCL- XL and MCL1 in Newly Diagnosed AML

Symptom Burden in Idiopathic Multicentric Castleman Disease: Protocol for the Development of a Novel Standardized Patient Reported Outcome Measure

Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL)

Decreased Survival Among Patients with Indolent Systemic Mastocytosis: A Population-Level Retrospective Cohort Analysis Using Healthcare Claims Dataset

Risk of Myelodysplastic Syndromes (MDS) in Adolescents and Young Adults with Cancers Treated with Chemotherapy with or without Radiotherapy

Risk of Therapy-Related Acute Myeloid Leukemia (t-AML) in Adolescent and Young Adults Cancer Patients Treated with Chemotherapy with or without Radiotherapy: A National Population-Based Cohort Study Using SEER Registry

A Model of Cumulative Risk of Disease Progression Among Patients with Indolent Systemic Mastocytosis

The Epidemiology of Cardiovascular Disease in African American Patients with Myeloid Neoplasms: A SEER Data Analysis

Race and Gender Representation in Myelodysplastic Syndrome Clinical Trials in the US: A Cohort Study

Risk of Therapy-Related Acute Myeloid Leukemia (t-AML) in Cancer Patients Treated with Chemotherapy with or without Radiotherapy: A National Population-Based Cohort Study Using SEER Registry

A Clinically Practicable Approach to Predict TP53 Allelic Configurations in Myeloid Neoplasia

Exploratory Validation of a Bespoke International Patient Symptom Survey in Idiopathic Multicentric Castleman's Disease Using Psychometric Testing: Implications for Clinical Practice and Routine Data Collection

Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Clinical and Molecular Features of FTL3 non Canonical and Activation Loop Mutations

Patterns of Disease Progression in Patients with Systemic Mastocytosis: A US Population-Level Analysis Using Health Claims-Based Dataset

Real-World Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Luspatercept: An Evaluation of US Clinical Practice Utilization and Treatment Patterns

Real-World Usage of Asciminib in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) in the United States (US) Using a Large Claims Database

ANKRD26 Coding Variants in Myeloid Neoplasia

Association of Clinical Characteristics at Diagnosis with Outcomes in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from a Real-World Medical Chart Review in the US

SEL24/MEN1703 Inhibits PIM/FLT3 Downstream Target in Acute Myeloid Leukemia (AML) Patients: Results of the Pharmacodynamics (PD) Assay and Genomic Profiling in the First-in-Human Diamond-01 Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only